Brio Capital Master Fund Ltd. 13D and 13G filings for Sigyn Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 10:47 am Purchase | 2022-01-27 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 93,146 9.990% | 7,766 (+9.10%) | Filing |
| 2021-01-27 12:35 pm Purchase | 2021-01-17 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 85,380 9.990% | 85,380 (New Position) | Filing |